Efinopegdutide (JNJ-64565111; HM12525A) is also a unimolecular once weekly GLP-1 and glucagon agonist that has been investigated in people with obesity, T2D and MASLD/MASH. This evidence concerns the gene GCG and type 2 diabetes mellitus.